SlideShare ist ein Scribd-Unternehmen logo
1 von 5
Downloaden Sie, um offline zu lesen
© Copyright 2010 INNOVATE LLC. publisher of The Innovators electronic magazine www.innovate1st.com
IInntteerrvviieeww wwiitthh UUssaammaa MMaalliikk
VViiccee PPrreessiiddeenntt aanndd HHeeaadd ooff BBuussiinneessss IInnnnoovvaattiioonn
PPffiizzeerr
Usama is the Vice President and Head of Business Innovation
at Pfizer Inc. He is focused on creating a sustaining culture of
Innovation within the company, while investing in
transformational & disruptive ideas that enhance existing
revenues or generate new ones, improve the company’s cost
structure, or reduce business risk. Previously, he was a senior
member of Pfizer’s Corporate Strategy group, and was
responsible for managing the day-to-day Pfizer-Wyeth
integration planning, among several other strategic initiatives.
Prior to Pfizer, Usama was a leader in Booz & Company’s
healthcare and life science strategy consulting practice. He
received his MBA from INSEAD, and his undergraduate degree
in Electrical Engineering from the University of Maryland,
College Park. He is a frequent speaker at health industry
conferences. Usama can be reached at
usama.malik@pfizer.com
Here Usama shares the approach his group is taking at Pfizer to successfully build and maintain a
culture of Innovation.
.
Interview conducted by Doug Berger, managing director, INNOVATE. doug@innovate1st.com
Doug: In heading Innovation at Pfizer, what were you asked to accomplish?
Usama: Innovation is one of Pfizer’s five corporate strategies established three years ago.
It is a continuation of our efforts to establish Pfizer as a leading Innovator in
science, business and policy. We are aiming to source new ideas, including
disruptive ideas, that shape and respond to changes in healthcare. Our focus is
multiple-fold. (1) To achieve new streams of high-growth cashflows. We are
providing Pfizer colleagues with the tools, channels, and funding to generate new
businesses both within and outside the company. We are continuing to invest in
high-value external networks with venture capitalists, private equity firms,
academia, entrepreneurs, and innovators across the world. (2)To lead healthcare
in the 21st
Century by developing new healthcare business models and approaches
that create new experiences and value for our customers and stakeholders. (3)
To hedge risks for the future depending on how healthcare develops in the 21st
century.
October 2010
Conversations
on the Cutting Edge
www.innovate1st.com
2
Doug: You have been leading this effort for 10 months. How have you been approaching
Innovation and how have you been thinking about impactng a company as large
and far-reaching as Pfizer?
Usama: We spent a lot of time upfront understanding what our baseline capabilities were,
thinking about successes and failures within Pfizer, and importantly, learning from
leading Innovators on the outside. Regarding lessons learned, there have been no
big single ah-ha’s, but the collective learnings are rich and insightful. It is critical
to take lessons like these into account when you’re building an innovation
competence.
We have learned that innovation is not an island. Innovation necessarily has to
follow corporate strategy so that it is focused, but to be truly successful in
establishing a culture of innovation that is meaningful to the business and to our
stakeholders, also requires executive leadership and commitment, persistence,
and hard work for many years. It generally takes four to six years to make
innovation a sustaining high-value competency for the company. Other learnings
include:
 Establishing clarity of vision, clear expectations (common goals, focus areas),
and defined outcomes to align, direct and harness the energy of the
organization
 Developing key Innovation leadership and talent
 Enabling expansive networks of people and ideas (internally and externally),
which is instrumental in achieving breakthrough business models
 Employing focus, rigor and discipline (processes, tools, systems) because
innovation is significantly more than creativity -- it is a rigorous and
disciplined process of commitment and execution
 Executing with prudent risk-taking, quick decision-making, and smart
experimentation
 “Embracing failure” and building a continuous “learning organization”
 Communicating frequently, persistently and with passion
Doug: Our readers would be very interested in hearing what you’ve been able to put in
place during that first ten months, and then looking out another year from now,
what you expect to put in place.
Usama: We’ve started to build a strong foundation through a company-wide Innovation
operating model, implementing novel business processes and culture-change
programs, and putting in place standard frameworks, systems and tools. With a
solid foundation in place, we expect to continue to advance an ambitious growth
and innovation agenda in the coming years by being focused, disciplined and
pragmatic in our approach. We’ve developed a transparent framework to help us
think about three types of innovation: sustaining, transformative and disruptive
innovation.
Sustaining innovations focus on optimizing our existing businesses through
capability, product, and process improvements that result in generating revenue
and cost efficiencies.
Transformative innovations focus on expanding our existing businesses through
capability, product and service investments to add new value by either increasing
market share, transforming the customer experience, or meaningfully changing a
cost structure.
3
Disruptive innovations focus on identifying, evaluating, investing in and building
new businesses or new business models to lead, shape and participate in the
emergent 21st
century healthcare systems that result in new value creation,
revenue streams and system-wide cost innovations.
Our job is to build a foundation so that we can create a sustainable mechanism for
achieving transformative and disruptive innovation in the company.
As an example, we have invested significant time and resources to develop a
proprietary, and what we consider to be the first of its kind in any company, end-
to-end Innovation Management Platform. This platform will enable our employees
to generate new ideas, and take these ideas from thought to implementation
using technology tools, virtual communities, social networking, automated
business plans, dynamic learning and development modules, ability to request
funding, etc. We’re using technology to empower our colleagues to move from
being ideators (idea generators) to becoming innovators and entrepreneurs.
Externally, we’ve developed a number of platforms, including our e-Health
capability, which focuses on thinking about the convergence of healthcare and
information technology. Over the last nine months, we’ve made three
investments in companies that are in the e-Health space: Private Access, Kia, and
Acacia Living. All three collaborations are centered on driving consumer-driven
outcomes-focused, technology-enabled healthcare. They’re in the vein of
personalizing care in a decentralized fashion so that consumers, their families and
caregivers are more empowered and more engaged – we aim to provide trusted
healthcare solutions that matter to them.
Another capability is looking at novel multi-player collaboration models between
large healthcare partners to solve complex industry-wide challenges. As an
example, one of the investments that we have made in the last year is with
Private Access to enable an industry-wide, public-private collaboration model to
advance patient recruitment in clinical development in ways meaningful to
patients and highly impactful for researchers.
Doug: The percent of companies that succeed in disruptive innovation is probably less
than 1 out of 4. What are the few critical things that you’re putting in place that
gives you a level of confidence?
Usama: When you are creating new business models that make existing ones obsolete,
obviously this threatens the status quo and obviously the status quo tries to
protect itself. So it’s necessary to protect these transformative and disruptive
ideas from the core business. There are at least two ways to do that.
One is to create a separate business unit within a company, an internal incubator
that is ring-fenced away from the rest of the businesses and is empowered to
create these businesses to a certain point of maturity. The other approach is to
create an external incubator outside of the company to do the same thing, which
is to invest in disruptive spaces and allow these companies the entrepreneurial
spirit and the freedom to operate so that they can actually become businesses in
their own right.
We have been pretty successful in advancing transformative ideas that allow for
new revenue streams from existing businesses within Pfizer.
4
For disruptive ideas, our approach has been to create an external incubation
model. We have been developing an external portfolio of companies that are
driven by a unified strategic intent and robust investment and portfolio logic.
They are all closely related and weave into an overall story of healthcare for the
21st
century – a story that is rooted in the personalization and decentralization of
health and wellness. It has enabled these partners on the outside to grow faster
by having access to the global brand, scale, and scope of a company like Pfizer,
but having the nimbleness and the flexibility of a startup. At the same time, we’re
working with a number of these external partners to enable new business
processes within the company in the near-term.
Doug: Let’s shift to more specific innovation areas and talk more about how you’re
approaching e-Health.
Usama: Healthcare is one of the last industries not to have embraced technology fully. I
think we’re at that inflection point where the state of the healthcare technology
industry, combined with healthcare reforms around the world, is creating
incentives for technology adoption. This is coupled with new, private venture
monies in technology-enabled healthcare models and a generation of providers,
caregivers and consumers who are willingly adopting technology-based healthcare
models at an accelerating pace. This convergence of healthcare and information
technology will be disruptive for the industry. Players that don’t embrace this
change will most likely not be able to adapt to the new systems of the 21st
century. The underlying trends supported by technologies like the –omics
technologies, new point-of-care predictive diagnostics, devices and health and
wellness applications, social networks, “quantified self,” broader data liquidity in
healthcare systems, virtual and remote care delivery and management, etc. will
be game-changing for healthcare.
Doug: In many industries the individual companies can implement electronic records at
their own discretion, at their own pace. You’re dealing with an environment in
which you’re just one of the players in order for e-Health to take root. How does
Pfizer view its role?
Usama: I highlighted at least ten different trends in e-Health, and only some of them
require large-scale policy changes. When it comes to data standards,
interoperability, data liquidity and information exchange protocols and other topics
that either touch on notions of “public good” or require a common approach across
multiple stakeholders, policy has a strong role to play. For the remainder, i.e.
market-driven solutions for consumers and providers that empower these groups,
create wholly new experiences for them, help them improve quality and access at
more affordable prices, provide them with meaningful choice … these will be
mostly shaped bottom-up by market forces. And in fact this is happening as we
speak. The concepts of virtual and remote care delivery are here. The idea of the
“quantified self” is here. The further empowerment of patients and patient
advocacy groups through the use of technology and social networks is here. In
short, the world is changing before our very eyes – we can choose to see these as
outlier trends or we can decide that these trends at the margin are in fact shaping
the very future and changing the entire game.
For those areas in which policy reform and collaboration is required, we’re
advancing the agenda on multiple fronts. For example, we’re participating along
with other Pharma companies and other public-private stakeholders in the New
York e-Health Collaborative (Pacer), which is building a sophisticated and avant-
5
garde health information exchange for the State of New York that is a model of
collaboration for the rest of the country.
Doug: Is there anything you’d like to say in conclusion?
Usama: This is the beginning of the beginning. Innovation is tough. The things that we
laid out up-front in terms of lessons learned are critical for other companies to
consider in building innovation as a competency and trying to overcome existing
barriers or create new environments. It is important to spend time up-front
thinking about what you want to get out of this before you start making the
investment. I think a fast pace will inevitably lead to failure from the start. Be
pragmatic and patient in your execution because it’s a long journey and there are
a lot of bumps in the road. Once you do get through that journey in four or five
years, you will have created an organization that has this sustainable capability to
continually innovate. At least that’s the hope.
Click to subscribe to The Innovators

Weitere ähnliche Inhalte

Was ist angesagt?

Oi in sme's remarks
Oi in sme's remarksOi in sme's remarks
Oi in sme's remarkspsaradis
 
Introduction to the economics of innovation
Introduction to the economics of innovationIntroduction to the economics of innovation
Introduction to the economics of innovationFogGuru MSCA Project
 
Realising the Value of Open Innovation
Realising the Value of Open InnovationRealising the Value of Open Innovation
Realising the Value of Open InnovationPrateek Sureka
 
Financing Innovation and Intellectual property
Financing Innovation and Intellectual property Financing Innovation and Intellectual property
Financing Innovation and Intellectual property FogGuru MSCA Project
 
Creating Competitive Advantage: Resource and Capabilities
Creating Competitive Advantage: Resource and Capabilities Creating Competitive Advantage: Resource and Capabilities
Creating Competitive Advantage: Resource and Capabilities FogGuru MSCA Project
 
Bcg cfa perth presentation
Bcg cfa perth presentationBcg cfa perth presentation
Bcg cfa perth presentationFelipe Sotelo A.
 
Fsu the entreprenurial university final
Fsu the entreprenurial university finalFsu the entreprenurial university final
Fsu the entreprenurial university finalstevenlroden
 
Strengthening the National Innovation System of the Philippines: A continuing...
Strengthening the National Innovation System of the Philippines: A continuing...Strengthening the National Innovation System of the Philippines: A continuing...
Strengthening the National Innovation System of the Philippines: A continuing...Raymund Habaradas
 
Ncms ayush guneet_glim
Ncms ayush guneet_glimNcms ayush guneet_glim
Ncms ayush guneet_glimguneet_arneja
 
Identifying Business Opportunity
Identifying Business OpportunityIdentifying Business Opportunity
Identifying Business OpportunityTan Denise
 
Policies for Growth - SIMPATIC 3 April 2014
Policies for Growth - SIMPATIC 3 April 2014Policies for Growth - SIMPATIC 3 April 2014
Policies for Growth - SIMPATIC 3 April 2014Dirk Pilat
 
Technology Startups in Tunisia: Specificities and finding challenges
Technology Startups in Tunisia: Specificities and finding challengesTechnology Startups in Tunisia: Specificities and finding challenges
Technology Startups in Tunisia: Specificities and finding challengesKawther ADHOUM
 
Market driven research
Market driven researchMarket driven research
Market driven researchMurray Hunter
 
Fsu the entreprenurial university
Fsu the entreprenurial universityFsu the entreprenurial university
Fsu the entreprenurial universitystevenlroden
 
Business idea sources
Business idea sourcesBusiness idea sources
Business idea sourcesChuck Eesley
 
ERC Research Showcase presentations 29.01.2018
ERC Research Showcase presentations 29.01.2018 ERC Research Showcase presentations 29.01.2018
ERC Research Showcase presentations 29.01.2018 enterpriseresearchcentre
 
TCIOceania14 Agricultural inputs, food and beverage industry
TCIOceania14 Agricultural inputs, food and beverage industryTCIOceania14 Agricultural inputs, food and beverage industry
TCIOceania14 Agricultural inputs, food and beverage industryTCI Network
 

Was ist angesagt? (20)

Oi in sme's remarks
Oi in sme's remarksOi in sme's remarks
Oi in sme's remarks
 
Introduction to the economics of innovation
Introduction to the economics of innovationIntroduction to the economics of innovation
Introduction to the economics of innovation
 
Realising the Value of Open Innovation
Realising the Value of Open InnovationRealising the Value of Open Innovation
Realising the Value of Open Innovation
 
Financing Innovation and Intellectual property
Financing Innovation and Intellectual property Financing Innovation and Intellectual property
Financing Innovation and Intellectual property
 
Creating Competitive Advantage: Resource and Capabilities
Creating Competitive Advantage: Resource and Capabilities Creating Competitive Advantage: Resource and Capabilities
Creating Competitive Advantage: Resource and Capabilities
 
Bcg cfa perth presentation
Bcg cfa perth presentationBcg cfa perth presentation
Bcg cfa perth presentation
 
Fsu the entreprenurial university final
Fsu the entreprenurial university finalFsu the entreprenurial university final
Fsu the entreprenurial university final
 
Strengthening the National Innovation System of the Philippines: A continuing...
Strengthening the National Innovation System of the Philippines: A continuing...Strengthening the National Innovation System of the Philippines: A continuing...
Strengthening the National Innovation System of the Philippines: A continuing...
 
Domaining Overview
Domaining OverviewDomaining Overview
Domaining Overview
 
Ncms ayush guneet_glim
Ncms ayush guneet_glimNcms ayush guneet_glim
Ncms ayush guneet_glim
 
Identifying Business Opportunity
Identifying Business OpportunityIdentifying Business Opportunity
Identifying Business Opportunity
 
Policies for Growth - SIMPATIC 3 April 2014
Policies for Growth - SIMPATIC 3 April 2014Policies for Growth - SIMPATIC 3 April 2014
Policies for Growth - SIMPATIC 3 April 2014
 
Technology Startups in Tunisia: Specificities and finding challenges
Technology Startups in Tunisia: Specificities and finding challengesTechnology Startups in Tunisia: Specificities and finding challenges
Technology Startups in Tunisia: Specificities and finding challenges
 
Entrepreneurship
EntrepreneurshipEntrepreneurship
Entrepreneurship
 
Market driven research
Market driven researchMarket driven research
Market driven research
 
Fsu the entreprenurial university
Fsu the entreprenurial universityFsu the entreprenurial university
Fsu the entreprenurial university
 
Business idea sources
Business idea sourcesBusiness idea sources
Business idea sources
 
ERC Research Showcase presentations 29.01.2018
ERC Research Showcase presentations 29.01.2018 ERC Research Showcase presentations 29.01.2018
ERC Research Showcase presentations 29.01.2018
 
Innovation india
Innovation indiaInnovation india
Innovation india
 
TCIOceania14 Agricultural inputs, food and beverage industry
TCIOceania14 Agricultural inputs, food and beverage industryTCIOceania14 Agricultural inputs, food and beverage industry
TCIOceania14 Agricultural inputs, food and beverage industry
 

Ähnlich wie Innovation Frameworks in Healthcare

McKinsey & Company : Talent Management and Knowledge Management
McKinsey & Company : Talent Management and Knowledge ManagementMcKinsey & Company : Talent Management and Knowledge Management
McKinsey & Company : Talent Management and Knowledge ManagementHarsh Tamakuwala
 
Future of work: Self-management, business purpose and employee engagement
Future of work: Self-management, business purpose and employee engagementFuture of work: Self-management, business purpose and employee engagement
Future of work: Self-management, business purpose and employee engagementCoincidencity
 
Read attachedpages about 3-M and their approach to innovationRes.docx
Read attachedpages about 3-M and their approach to innovationRes.docxRead attachedpages about 3-M and their approach to innovationRes.docx
Read attachedpages about 3-M and their approach to innovationRes.docxmakdul
 
Innovation model for organizations
Innovation model for organizationsInnovation model for organizations
Innovation model for organizationsMercy Akinseinde
 
Technology Trust 08 24 09 Power Point Final
Technology Trust 08 24 09 Power Point FinalTechnology Trust 08 24 09 Power Point Final
Technology Trust 08 24 09 Power Point Finaljhustad1
 
Winning together
Winning  together Winning  together
Winning together FabMob
 
Innovating in Good Times & in Bad: Best Practices in Innovation
Innovating in Good Times & in Bad: Best Practices in InnovationInnovating in Good Times & in Bad: Best Practices in Innovation
Innovating in Good Times & in Bad: Best Practices in Innovationfuturethink
 
Generic Model Tailoring Questions Copyright Patrick
Generic Model Tailoring Questions Copyright PatrickGeneric Model Tailoring Questions Copyright Patrick
Generic Model Tailoring Questions Copyright PatrickChuck Patrick
 
Digital Health Success Stories (and Failures) Report - Part 2
Digital Health Success Stories (and Failures) Report - Part 2Digital Health Success Stories (and Failures) Report - Part 2
Digital Health Success Stories (and Failures) Report - Part 2Tom Parsons
 
Instructions In response to your classmates, comment on their des.docx
Instructions In response to your classmates, comment on their des.docxInstructions In response to your classmates, comment on their des.docx
Instructions In response to your classmates, comment on their des.docxsharondabriggs
 
Pauline Hanson Essay
Pauline Hanson EssayPauline Hanson Essay
Pauline Hanson EssayEmily Garcia
 
Service Innovation.pptx
Service Innovation.pptxService Innovation.pptx
Service Innovation.pptxAnkitaAnki16
 
When to Dive into Open Innovation
When to Dive into Open InnovationWhen to Dive into Open Innovation
When to Dive into Open InnovationStephen Clulow
 
the importance of corporate social responsibility and business ethics
the importance of corporate social responsibility and business ethicsthe importance of corporate social responsibility and business ethics
the importance of corporate social responsibility and business ethicsijtsrd
 
Organizational models for innovation
Organizational models for innovationOrganizational models for innovation
Organizational models for innovationJesus Parangue
 
Organizational models for innovation
Organizational models for innovationOrganizational models for innovation
Organizational models for innovationJesus Parangue
 

Ähnlich wie Innovation Frameworks in Healthcare (20)

McKinsey & Company : Talent Management and Knowledge Management
McKinsey & Company : Talent Management and Knowledge ManagementMcKinsey & Company : Talent Management and Knowledge Management
McKinsey & Company : Talent Management and Knowledge Management
 
Future of work: Self-management, business purpose and employee engagement
Future of work: Self-management, business purpose and employee engagementFuture of work: Self-management, business purpose and employee engagement
Future of work: Self-management, business purpose and employee engagement
 
Future of work: self-management
Future of work: self-managementFuture of work: self-management
Future of work: self-management
 
Read attachedpages about 3-M and their approach to innovationRes.docx
Read attachedpages about 3-M and their approach to innovationRes.docxRead attachedpages about 3-M and their approach to innovationRes.docx
Read attachedpages about 3-M and their approach to innovationRes.docx
 
Innovation model for organizations
Innovation model for organizationsInnovation model for organizations
Innovation model for organizations
 
Technology Trust 08 24 09 Power Point Final
Technology Trust 08 24 09 Power Point FinalTechnology Trust 08 24 09 Power Point Final
Technology Trust 08 24 09 Power Point Final
 
Intrapreneurship
IntrapreneurshipIntrapreneurship
Intrapreneurship
 
Winning together
Winning  together Winning  together
Winning together
 
Innovating in Good Times & in Bad: Best Practices in Innovation
Innovating in Good Times & in Bad: Best Practices in InnovationInnovating in Good Times & in Bad: Best Practices in Innovation
Innovating in Good Times & in Bad: Best Practices in Innovation
 
Benefits of Intrapreneurship
Benefits of IntrapreneurshipBenefits of Intrapreneurship
Benefits of Intrapreneurship
 
Generic Model Tailoring Questions Copyright Patrick
Generic Model Tailoring Questions Copyright PatrickGeneric Model Tailoring Questions Copyright Patrick
Generic Model Tailoring Questions Copyright Patrick
 
Digital Health Success Stories (and Failures) Report - Part 2
Digital Health Success Stories (and Failures) Report - Part 2Digital Health Success Stories (and Failures) Report - Part 2
Digital Health Success Stories (and Failures) Report - Part 2
 
Instructions In response to your classmates, comment on their des.docx
Instructions In response to your classmates, comment on their des.docxInstructions In response to your classmates, comment on their des.docx
Instructions In response to your classmates, comment on their des.docx
 
Pauline Hanson Essay
Pauline Hanson EssayPauline Hanson Essay
Pauline Hanson Essay
 
Service Innovation.pptx
Service Innovation.pptxService Innovation.pptx
Service Innovation.pptx
 
When to Dive into Open Innovation
When to Dive into Open InnovationWhen to Dive into Open Innovation
When to Dive into Open Innovation
 
Innovative Hr Practices
Innovative Hr PracticesInnovative Hr Practices
Innovative Hr Practices
 
the importance of corporate social responsibility and business ethics
the importance of corporate social responsibility and business ethicsthe importance of corporate social responsibility and business ethics
the importance of corporate social responsibility and business ethics
 
Organizational models for innovation
Organizational models for innovationOrganizational models for innovation
Organizational models for innovation
 
Organizational models for innovation
Organizational models for innovationOrganizational models for innovation
Organizational models for innovation
 

Mehr von Usama Malik

Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Usama Malik
 
Clinical trial recruitment overview
Clinical trial recruitment overviewClinical trial recruitment overview
Clinical trial recruitment overviewUsama Malik
 
Innovation in nutrition
Innovation in nutritionInnovation in nutrition
Innovation in nutritionUsama Malik
 
Economic development concepts
Economic development conceptsEconomic development concepts
Economic development conceptsUsama Malik
 
CRO Industry Overview
CRO Industry OverviewCRO Industry Overview
CRO Industry OverviewUsama Malik
 
Digital health overview
Digital health overviewDigital health overview
Digital health overviewUsama Malik
 
Retail industry trends overview
Retail industry trends overviewRetail industry trends overview
Retail industry trends overviewUsama Malik
 

Mehr von Usama Malik (7)

Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Major healthcare delivery trends 2015
Major healthcare delivery trends 2015
 
Clinical trial recruitment overview
Clinical trial recruitment overviewClinical trial recruitment overview
Clinical trial recruitment overview
 
Innovation in nutrition
Innovation in nutritionInnovation in nutrition
Innovation in nutrition
 
Economic development concepts
Economic development conceptsEconomic development concepts
Economic development concepts
 
CRO Industry Overview
CRO Industry OverviewCRO Industry Overview
CRO Industry Overview
 
Digital health overview
Digital health overviewDigital health overview
Digital health overview
 
Retail industry trends overview
Retail industry trends overviewRetail industry trends overview
Retail industry trends overview
 

Kürzlich hochgeladen

"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdfDolisha Warbi
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementIris Thiele Isip-Tan
 
person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxMUKESH PADMANABHAN
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychologyshantisphysio
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha KewatNehaKewat
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborHealth Catalyst
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxPamela McKinney
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdfCompliatric Where Compliance Happens
 
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11crzljavier
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxsandhulove46637
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 
EYE CANCER.pptx prepared by Neha kewat digital learning
EYE CANCER.pptx prepared by  Neha kewat digital learningEYE CANCER.pptx prepared by  Neha kewat digital learning
EYE CANCER.pptx prepared by Neha kewat digital learningNehaKewat
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareratilalthakkar704
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLyons Health
 
Empathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadEmpathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadAlex Clapson
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal TutorNehaKewat
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024Traumasoft LLC
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYRMC
 

Kürzlich hochgeladen (20)

"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
 
person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptx
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychology
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and Labor
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptx
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
 
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptx
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 
EYE CANCER.pptx prepared by Neha kewat digital learning
EYE CANCER.pptx prepared by  Neha kewat digital learningEYE CANCER.pptx prepared by  Neha kewat digital learning
EYE CANCER.pptx prepared by Neha kewat digital learning
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCare
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
 
Empathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadEmpathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion instead
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal Tutor
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
 
SCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATIONSCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATION
 

Innovation Frameworks in Healthcare

  • 1. © Copyright 2010 INNOVATE LLC. publisher of The Innovators electronic magazine www.innovate1st.com IInntteerrvviieeww wwiitthh UUssaammaa MMaalliikk VViiccee PPrreessiiddeenntt aanndd HHeeaadd ooff BBuussiinneessss IInnnnoovvaattiioonn PPffiizzeerr Usama is the Vice President and Head of Business Innovation at Pfizer Inc. He is focused on creating a sustaining culture of Innovation within the company, while investing in transformational & disruptive ideas that enhance existing revenues or generate new ones, improve the company’s cost structure, or reduce business risk. Previously, he was a senior member of Pfizer’s Corporate Strategy group, and was responsible for managing the day-to-day Pfizer-Wyeth integration planning, among several other strategic initiatives. Prior to Pfizer, Usama was a leader in Booz & Company’s healthcare and life science strategy consulting practice. He received his MBA from INSEAD, and his undergraduate degree in Electrical Engineering from the University of Maryland, College Park. He is a frequent speaker at health industry conferences. Usama can be reached at usama.malik@pfizer.com Here Usama shares the approach his group is taking at Pfizer to successfully build and maintain a culture of Innovation. . Interview conducted by Doug Berger, managing director, INNOVATE. doug@innovate1st.com Doug: In heading Innovation at Pfizer, what were you asked to accomplish? Usama: Innovation is one of Pfizer’s five corporate strategies established three years ago. It is a continuation of our efforts to establish Pfizer as a leading Innovator in science, business and policy. We are aiming to source new ideas, including disruptive ideas, that shape and respond to changes in healthcare. Our focus is multiple-fold. (1) To achieve new streams of high-growth cashflows. We are providing Pfizer colleagues with the tools, channels, and funding to generate new businesses both within and outside the company. We are continuing to invest in high-value external networks with venture capitalists, private equity firms, academia, entrepreneurs, and innovators across the world. (2)To lead healthcare in the 21st Century by developing new healthcare business models and approaches that create new experiences and value for our customers and stakeholders. (3) To hedge risks for the future depending on how healthcare develops in the 21st century. October 2010 Conversations on the Cutting Edge www.innovate1st.com
  • 2. 2 Doug: You have been leading this effort for 10 months. How have you been approaching Innovation and how have you been thinking about impactng a company as large and far-reaching as Pfizer? Usama: We spent a lot of time upfront understanding what our baseline capabilities were, thinking about successes and failures within Pfizer, and importantly, learning from leading Innovators on the outside. Regarding lessons learned, there have been no big single ah-ha’s, but the collective learnings are rich and insightful. It is critical to take lessons like these into account when you’re building an innovation competence. We have learned that innovation is not an island. Innovation necessarily has to follow corporate strategy so that it is focused, but to be truly successful in establishing a culture of innovation that is meaningful to the business and to our stakeholders, also requires executive leadership and commitment, persistence, and hard work for many years. It generally takes four to six years to make innovation a sustaining high-value competency for the company. Other learnings include:  Establishing clarity of vision, clear expectations (common goals, focus areas), and defined outcomes to align, direct and harness the energy of the organization  Developing key Innovation leadership and talent  Enabling expansive networks of people and ideas (internally and externally), which is instrumental in achieving breakthrough business models  Employing focus, rigor and discipline (processes, tools, systems) because innovation is significantly more than creativity -- it is a rigorous and disciplined process of commitment and execution  Executing with prudent risk-taking, quick decision-making, and smart experimentation  “Embracing failure” and building a continuous “learning organization”  Communicating frequently, persistently and with passion Doug: Our readers would be very interested in hearing what you’ve been able to put in place during that first ten months, and then looking out another year from now, what you expect to put in place. Usama: We’ve started to build a strong foundation through a company-wide Innovation operating model, implementing novel business processes and culture-change programs, and putting in place standard frameworks, systems and tools. With a solid foundation in place, we expect to continue to advance an ambitious growth and innovation agenda in the coming years by being focused, disciplined and pragmatic in our approach. We’ve developed a transparent framework to help us think about three types of innovation: sustaining, transformative and disruptive innovation. Sustaining innovations focus on optimizing our existing businesses through capability, product, and process improvements that result in generating revenue and cost efficiencies. Transformative innovations focus on expanding our existing businesses through capability, product and service investments to add new value by either increasing market share, transforming the customer experience, or meaningfully changing a cost structure.
  • 3. 3 Disruptive innovations focus on identifying, evaluating, investing in and building new businesses or new business models to lead, shape and participate in the emergent 21st century healthcare systems that result in new value creation, revenue streams and system-wide cost innovations. Our job is to build a foundation so that we can create a sustainable mechanism for achieving transformative and disruptive innovation in the company. As an example, we have invested significant time and resources to develop a proprietary, and what we consider to be the first of its kind in any company, end- to-end Innovation Management Platform. This platform will enable our employees to generate new ideas, and take these ideas from thought to implementation using technology tools, virtual communities, social networking, automated business plans, dynamic learning and development modules, ability to request funding, etc. We’re using technology to empower our colleagues to move from being ideators (idea generators) to becoming innovators and entrepreneurs. Externally, we’ve developed a number of platforms, including our e-Health capability, which focuses on thinking about the convergence of healthcare and information technology. Over the last nine months, we’ve made three investments in companies that are in the e-Health space: Private Access, Kia, and Acacia Living. All three collaborations are centered on driving consumer-driven outcomes-focused, technology-enabled healthcare. They’re in the vein of personalizing care in a decentralized fashion so that consumers, their families and caregivers are more empowered and more engaged – we aim to provide trusted healthcare solutions that matter to them. Another capability is looking at novel multi-player collaboration models between large healthcare partners to solve complex industry-wide challenges. As an example, one of the investments that we have made in the last year is with Private Access to enable an industry-wide, public-private collaboration model to advance patient recruitment in clinical development in ways meaningful to patients and highly impactful for researchers. Doug: The percent of companies that succeed in disruptive innovation is probably less than 1 out of 4. What are the few critical things that you’re putting in place that gives you a level of confidence? Usama: When you are creating new business models that make existing ones obsolete, obviously this threatens the status quo and obviously the status quo tries to protect itself. So it’s necessary to protect these transformative and disruptive ideas from the core business. There are at least two ways to do that. One is to create a separate business unit within a company, an internal incubator that is ring-fenced away from the rest of the businesses and is empowered to create these businesses to a certain point of maturity. The other approach is to create an external incubator outside of the company to do the same thing, which is to invest in disruptive spaces and allow these companies the entrepreneurial spirit and the freedom to operate so that they can actually become businesses in their own right. We have been pretty successful in advancing transformative ideas that allow for new revenue streams from existing businesses within Pfizer.
  • 4. 4 For disruptive ideas, our approach has been to create an external incubation model. We have been developing an external portfolio of companies that are driven by a unified strategic intent and robust investment and portfolio logic. They are all closely related and weave into an overall story of healthcare for the 21st century – a story that is rooted in the personalization and decentralization of health and wellness. It has enabled these partners on the outside to grow faster by having access to the global brand, scale, and scope of a company like Pfizer, but having the nimbleness and the flexibility of a startup. At the same time, we’re working with a number of these external partners to enable new business processes within the company in the near-term. Doug: Let’s shift to more specific innovation areas and talk more about how you’re approaching e-Health. Usama: Healthcare is one of the last industries not to have embraced technology fully. I think we’re at that inflection point where the state of the healthcare technology industry, combined with healthcare reforms around the world, is creating incentives for technology adoption. This is coupled with new, private venture monies in technology-enabled healthcare models and a generation of providers, caregivers and consumers who are willingly adopting technology-based healthcare models at an accelerating pace. This convergence of healthcare and information technology will be disruptive for the industry. Players that don’t embrace this change will most likely not be able to adapt to the new systems of the 21st century. The underlying trends supported by technologies like the –omics technologies, new point-of-care predictive diagnostics, devices and health and wellness applications, social networks, “quantified self,” broader data liquidity in healthcare systems, virtual and remote care delivery and management, etc. will be game-changing for healthcare. Doug: In many industries the individual companies can implement electronic records at their own discretion, at their own pace. You’re dealing with an environment in which you’re just one of the players in order for e-Health to take root. How does Pfizer view its role? Usama: I highlighted at least ten different trends in e-Health, and only some of them require large-scale policy changes. When it comes to data standards, interoperability, data liquidity and information exchange protocols and other topics that either touch on notions of “public good” or require a common approach across multiple stakeholders, policy has a strong role to play. For the remainder, i.e. market-driven solutions for consumers and providers that empower these groups, create wholly new experiences for them, help them improve quality and access at more affordable prices, provide them with meaningful choice … these will be mostly shaped bottom-up by market forces. And in fact this is happening as we speak. The concepts of virtual and remote care delivery are here. The idea of the “quantified self” is here. The further empowerment of patients and patient advocacy groups through the use of technology and social networks is here. In short, the world is changing before our very eyes – we can choose to see these as outlier trends or we can decide that these trends at the margin are in fact shaping the very future and changing the entire game. For those areas in which policy reform and collaboration is required, we’re advancing the agenda on multiple fronts. For example, we’re participating along with other Pharma companies and other public-private stakeholders in the New York e-Health Collaborative (Pacer), which is building a sophisticated and avant-
  • 5. 5 garde health information exchange for the State of New York that is a model of collaboration for the rest of the country. Doug: Is there anything you’d like to say in conclusion? Usama: This is the beginning of the beginning. Innovation is tough. The things that we laid out up-front in terms of lessons learned are critical for other companies to consider in building innovation as a competency and trying to overcome existing barriers or create new environments. It is important to spend time up-front thinking about what you want to get out of this before you start making the investment. I think a fast pace will inevitably lead to failure from the start. Be pragmatic and patient in your execution because it’s a long journey and there are a lot of bumps in the road. Once you do get through that journey in four or five years, you will have created an organization that has this sustainable capability to continually innovate. At least that’s the hope. Click to subscribe to The Innovators